bioRxivPharmacology & ToxicologyPreprint
An anti-SARS-CoV-2 formula consisting volatile oil from TCM through inhibiting multiple targets in cultured cells
Huan ZhangiD, Wuyan Guo, Jing SheniD, Xiaorui SongiD, Bo ZhangiD
- Citations
- 0
Abstract
At present, coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variant virus are prevalent all over the world, taking a major toll on human lives worldwide. Oral mucosa and saliva are the high-risk routes of transmission. Inactivation of the virus in the mouth is one of the important strategies to reduce the source infectivity of the virus. However, the current preparations for inactivating oral virus are mainly aimed at ACE2 protein, and its effect needs to be improved. In this study, through literature mining, multi-target screening and other methods, we screened and optimized the volatile oil formula (Artemisiae argyi folium, Chrysanthemum morifolium, Trollii chinensis flos, Lonicerae japonicae flos) from the volatile oil of traditional Chinese medicine to inhibit the invasion and replication of SARS-CoV-2. A test using pseudotype virus with S glycoprotein confirmed that this formula could effectively bind to the S glycoprotein to prevent SARS-CoV-2 host cell entry. Molecular docking experiments showed that the m ultiple molecules in the formula might weakly bind to these targets including ACE2, cathepsin L, furin, mpro/3cl. In all, the volatile oil formula designed in this paper offers a general affordable strategy to protect patients from SARS-CoV-2 infections through debulking or minimizing transmission to others.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- In vitro efficacy of Artemisia extracts against SARS-CoV-2
C. Nie, J. Trimpert, … P. H. Seeberger·bioRxiv·Feb 14, 2021
- Prophylactic and Therapeutic Inhibition of In Vitro SARS-CoV-2 Replication by Oleandrin
K. S. Plante, J. A. Plante, … S. C. Weaver·bioRxiv·Jul 15, 2020
- Effective in-vitro inactivation of SARS-CoV-2 by commercially available mouthwashes
K. Davies, H. Buczkowski, … M. J. Killip·bioRxiv·Dec 2, 2020
- The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2, in vitro
Riho Tateyama‐Makino, Mari Abe-Yutori, … Keiichi Tsukinoki·PLoS ONEPeer-reviewed·Sep 17, 2021
- Rapid inactivation in vitro of SARS-CoV-2 in saliva by black tea and green tea
E. Ohgitani, M. Shin-Ya, … O. Mazda·bioRxiv·Dec 28, 2020
- Vinegar and Its Active Component Acetic Acid Inhibit SARS-CoV-2 Infection In Vitro and Ex Vivo
I. Pagani, S. Ghezzi, … E. Vicenzi·bioRxiv·Jul 8, 2020